565 related articles for article (PubMed ID: 16263229)
1. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
2. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
Aggarwal D; Garg A; Kaur IP
J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
[TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
4. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor.
Aggarwal D; Pal D; Mitra AK; Kaur IP
Int J Pharm; 2007 Jun; 338(1-2):21-6. PubMed ID: 17300885
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of niosomes containing ribavirin for liver targeting.
Hashim F; El-Ridy M; Nasr M; Abdallah Y
Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
[TBL] [Abstract][Full Text] [Related]
6. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
7. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
Mokhtar M; Sammour OA; Hammad MA; Megrab NA
Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
[TBL] [Abstract][Full Text] [Related]
8. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
Verma P; Gupta RN; Jha AK; Pandey R
Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
[TBL] [Abstract][Full Text] [Related]
9. An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration.
Palma SD; Tartara LI; Quinteros D; Allemandi DA; Longhi MR; Granero GE
J Control Release; 2009 Aug; 138(1):24-31. PubMed ID: 19426769
[TBL] [Abstract][Full Text] [Related]
10. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
12. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
13. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
15. Potential use of niosomal hydrogel as an ocular delivery system for atenolol.
Abu Hashim II; El-Dahan MS; Yusif RM; Abd-Elgawad AE; Arima H
Biol Pharm Bull; 2014; 37(4):541-51. PubMed ID: 24694602
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.
Yasin MN; Hussain S; Malik F; Hameed A; Sultan T; Qureshi F; Riaz H; Perveen G; Wajid A
Pak J Pharm Sci; 2012 Jan; 25(1):117-21. PubMed ID: 22186318
[TBL] [Abstract][Full Text] [Related]
17. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
Hathout RM; Mansour S; Mortada ND; Guinedi AS
AAPS PharmSciTech; 2007 Jan; 8(1):1. PubMed ID: 17408209
[TBL] [Abstract][Full Text] [Related]
18. Improvement of acetazolamide ocular permeation using ascorbyl laurate nanostructures as drug delivery system.
Tártara LI; Quinteros DA; Saino V; Allemandi DA; Palma SD
J Ocul Pharmacol Ther; 2012 Apr; 28(2):102-9. PubMed ID: 22060001
[TBL] [Abstract][Full Text] [Related]
19. Mannosylated niosomes as carrier adjuvant system for topical immunization.
Jain S; Vyas SP
J Pharm Pharmacol; 2005 Sep; 57(9):1177-84. PubMed ID: 16105238
[TBL] [Abstract][Full Text] [Related]
20. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]